楼主: 嘉雯twins
1519 0

中银国际-医药行业更新报告-0316 英文  关闭 [推广有奖]

  • 0关注
  • 0粉丝

已卖:2010份资源

博士生

36%

还不是VIP/贵宾

-

威望
0
论坛币
7160 个
通用积分
0.0600
学术水平
2 点
热心指数
2 点
信用等级
2 点
经验
1672 点
帖子
144
精华
0
在线时间
0 小时
注册时间
2006-12-30
最后登录
2007-10-20

楼主
嘉雯twins 发表于 2007-3-18 11:40:00 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币

中银国际-医药行业更新报告-

16 March 2007 (Friday) 2页 英文

100139.pdf (181.23 KB)

SFDA revises medicine registration management rules.
On 10 March 2007, the State Food and Drug Administration (SFDA)
issued on its website a draft report on medicine registration
management rules to seek opinions over the next two months. The
medicine registration management rules define new medicines and
the rights of their owners. It also gives a guidance on how to obtain
certifications for drugs and ways to meet other necessary requirements.
The draft looks into ways to prevent the government from abusing its
powers. It also defines new drugs (those that have never been sold in
the country). Under the draft regulation, medicines in fresh packages
and of new specifications will not be deemed to be new products

二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:医药行业 中银国际 registration Requirements Requirement 国际 英文 医药行业 中银

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
加好友,备注jr
拉您进交流群
GMT+8, 2025-12-25 19:56